# XERIS BIOPHARMA HOLDINGS INC NOTE  8.000% 7/1

XERIS BIOPHARMA HOLDINGS INC NOTE  8.000% 7/1 is a security (CUSIP 98422EAB9) tracked across SEC portfolio filings. 3 institutional managers reported $68.7M on Form 13F as of 2026-03-31.

## Summary

- Issuer: XERIS BIOPHARMA HOLDINGS INC
- Class: NOTE  8.000% 7/1
- CUSIP: 98422EAB9
- 13F holders: 3
- 13F value: $68.7M
- 13F period: 2026-03-31
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [CAPSTONE INVESTMENT ADVISORS, LLC](https://search.stillhousedata.com/firm/155563) | NEW YORK, NY | $47.2M | 23,074,000 |
| [Polar Asset Management Partners Inc.](https://search.stillhousedata.com/firm/162681) | TORONTO, A6 | $21.5M | 10,500,000 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/98422EAB9.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.